Forskolin is known for its ability to raise intracellular cAMP levels. The surge in cAMP activates protein kinase A (PKA), a catalytic entity adept at phosphorylating a multitude of target proteins, potentially altering the activity state of FAM195A. Similarly, Dibutyryl-cAMP, a cell-permeable cAMP analog, serves the same end by directly activating PKA and thus may also modulate the phosphorylation status of FAM195A. Conversely, compounds like PMA and Genistein exert their effects by engaging with the kinase signaling cascades, albeit in different manners. PMA is a potent activator of protein kinase C (PKC), which is instrumental in phosphorylating serine and threonine residues on target proteins, a modification that can directly activate proteins analogous to FAM195A. Genistein, while primarily acting as a tyrosine kinase inhibitor, is also known to inadvertently activate other kinases, which may indirectly influence the phosphorylation and activity of FAM195A.
Calcium signaling plays a pivotal role in cellular processes, and Ionomycin powerfully demonstrates this by elevating intracellular calcium levels, thereby activating calmodulin-dependent kinases that are implicated in phosphorylating proteins, a fate FAM195A could share under such conditions. Kinase inhibitors such as LY294002 and PD98059, while primarily functioning as suppressors of specific kinases like PI3K and MEK, respectively, can lead to an intricate interplay within cellular signaling networks. This interplay might result in the activation of alternative pathways that include proteins resembling FAM195A. Phosphatase inhibitors, including Okadaic acid and Sodium orthovanadate, result in a cumulative increase in phosphorylated proteins by preventing dephosphorylation-a post-translational modification that typically serves to deactivate proteins. In this milieu, FAM195A could experience heightened activity due to such sustained phosphorylation. Anisomycin, which triggers a cellular stress response, can also lead to the activation of stress-related signaling pathways that affect proteins similar to FAM195A.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Directly activates protein kinase C (PKC), which can lead to the phosphorylation and activation of proteins related to FAM195A. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Acts as a tyrosine kinase inhibitor, but can also non-specifically activate other kinases, which may phosphorylate and activate a protein like FAM195A. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially activating calmodulin-dependent kinases which could phosphorylate and enhance the activity of proteins such as FAM195A. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, leading to altered cellular responses which can include the activation of proteins in pathways related to FAM195A. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may lead to compensatory activation of kinases in pathways that include proteins similar to FAM195A. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially affecting pathways that could activate a protein like FAM195A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits serine/threonine phosphatases, leading to increased phosphorylation levels of many proteins, which may include FAM195A. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibits protein tyrosine phosphatases, which can lead to enhanced activation of tyrosine phosphorylated proteins, potentially including FAM195A. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Acts as a protein synthesis inhibitor, triggering stress response pathways that can lead to the activation of proteins like FAM195A. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A cAMP analog that can penetrate cell membranes and activate PKA, potentially leading to the phosphorylation and activation of FAM195A. | ||||||